Non-Viral TCR Gene Therapy

NCT04102436 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Difficulty with availability of GLP-grade reagents for manufacturing.

Conditions

Endocrine/Neuroendocrine
Non-Small Cell Lung Cancer
Breast Cancer
Gastrointestinal/Genitourinary Cancers
Ovarian Cancer

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Aldesleukin
BIOLOGICAL: Sleeping Beauty Transposed PBL

Sponsor

National Cancer Institute (NCI)